Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Called “Insulin Lispro,” the generic version of Humalog may benefit those paying cash or with high-deductible health plans
If approved, Lilly’s intranasal glucagon would be a radical ease-of-use improvement over current glucagon kits for severe hypoglycemia
JDRF Chief Mission Officer Dr. Aaron Kowalski has been named the organization’s next President and CEO. See our exclusive interview with Dr. Kowalski!
CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s...
A study finds that packaged snacks, pre-prepared meals, and other “ultra-processed” foods lead to weight gain; unprocessed foods lead to weight loss
Surprising study findings from a look at refrigerator temperatures and the risk posed to insulin quality; plus, a guide to safe insulin storage and Med Angel’s very cool...
Low-carb pizza, low-cost produce home delivered, staying in-range during long exercise (UCAN), getting paid for steps, and Starbucks’ egg bites
Read about a new cauliflower pizza crust, alongside updates on Senseonics Eversense CGM, Medtronic’s new CGM points program, the Beyond A1C movement, Tandem’s Basal-IQ,...
FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.
Over 160 children and teens living with type 1 diabetes were selected to travel to Washington D.C. for three days, meeting with politicians and lawmakers to advocate for...
Farxiga and Zynquista are recommended for approval for people with type 1 diabetes in Europe with emphasis on DKA safety; EMA approval likely in coming months and hope...
Companion Medical's InPen is now available in 60,000 retail pharmacies across the United States
Control-IQ hybrid closed loop coming in summer 2019; paired app coming soon to the US; plans for the t:sport “patch” pump; and t:slim X2 pump launched outside the US
An inside look into former Aetna CEO Mark Bertolini's book, "Mission Driven Leadership: My Journey as a Radical Capitalist"
We asked diabetes experts for their advice for people with diabetes. They emphasized being your own advocate, finding community, technology, and always asking questions
Xeris’ Glucagon Rescue Pen, designed as an auto-injector, features a ready-to-use liquid glucagon – a safer and more convenient treatment option for severe hypoglycemia
Diabeloop’s automated insulin delivery system includes the Kaleido insulin pump, an Android controller, and the Dexcom G6 CGM; it is the second hybrid closed loop...
A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!
The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy.
New guidelines by the US Department of Health and Human Services emphasize the benefit of ANY increased physical activity

Pages